Acute coronary syndrome quality improvement in Kerala (ACS QUIK): Rationale and design for a cluster-randomized stepped-wedge trial

American Heart Journal

Volumn 185, Issue , 2017, Pages 154-160

  Huffman, Mark D ^a   Mohanan, Padinhare Purayil ^b   Devarajan, Raji ^c   Baldridge, Abigail S ^a   Kondal, Dimple ^c   Zhao, Lihui ^a   Ali, Mumtaj ^d   Lloyd Jones, Donald M ^a   Prabhakaran, Dorairaj ^c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Cardiology   (India)

^c Centre for Chronic Disease Control   (India)

^d PUBLIC HEALTH FOUNDATION OF INDIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HEALTH CARE COST; HEART CATHETERIZATION; HUMAN; KERALA; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STUDY DESIGN; TOTAL QUALITY MANAGEMENT; HEMORRHAGE; INDIA; MORTALITY; MYOCARDIAL INFARCTION; PRACTICE GAP; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; RECURRENT DISEASE; STROKE; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; GUIDELINE ADHERENCE; HEMORRHAGE; HUMANS; INDIA; MORTALITY; MYOCARDIAL INFARCTION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL PRACTICE GAPS; QUALITY IMPROVEMENT; RECURRENCE; STROKE;

EID: 85008500337     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2016.10.026     Document Type: Article

References (30)

1. 1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:9963 (2014), 117–171.
2. 2. Moran, A.E., Forouzanfar, M.H., Roth, G.A., et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: The Global Burden of Disease 2010 study. Circulation 129:14 (2014), 1483–1492.
3. 3. Roth, G.A., Forouzanfar, M.H., Moran, A.E., et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 372:14 (2015), 1333–1341.
4. 4. Mohanan, P.P., Mathew, R., Harikrishnan, S., et al. Presentation, management, and outcomes of 25,748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J 34:2 (2013), 121–129.
5. 5. Huffman, M.D., Prabhakaran, D., Abraham, A.K., et al. Optimal in-hospital and discharge medical therapy in acute coronary syndromes in Kerala: results from the Kerala Acute Coronary Syndrome Registry. Circ Cardiovasc Qual Outcomes 6:4 (2013), 436–443.
6. 6. Peterson, E.D., Roe, M.T., Mulgund, J., et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 295:16 (2006), 1912–1920.
7. 7. Berwanger, O., Guimarães, H.P., Laranjeira, L.N., et al. Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial. JAMA 307:19 (2012), 2041–2049.
8. 8. Du, X., Gao, R., Turnbull, F., et al. Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trial. Circ Cardiovasc Qual Outcomes 7:2 (2014), 217–226.
9. 9. Li, S., Wu, Y., Du, X., et al. Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China. Am Heart J 169:3 (2015), 349–355.
10. 10. Prabhakaran, D., Jeemon, P., Mohanan, P.P., et al. Management of acute coronary syndromes in secondary care settings in Kerala: impact of a quality improvement programme. Natl Med J India 21:3 (2008), 107–111.
11. 11. Alexander, T., Victor, S.M., Mullasari, A.S., et al. Protocol for a prospective, controlled study of assertive, and timely reperfusion for patients with ST-segment elevation myocardial infarction in Tamil Nadu: the TN-STEMI programme. BMJ Open, 3(12), 2013, e003850.
12. 12. Chan, A.-W., Tetzlaff, J.M., Gøtzsche, P.C., et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ, 346(jan08 15), 2013, e7586.
13. 13. Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. Circulation 126:16 (2012), 2020–2035.
14. 14. Cannon, C.P., Brindis, R.G., Chaitman, B.R., et al. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards). Circulation 127:9 (2013), 1052–1089.
15. 15. Craig, P., Dieppe, P., Macintyre, S., et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ, 337, 2008, a1655.
16. 16. Ivers, N., Jamtvedt, G., Flottorp, S., et al. Audit and feedback: effects on professional practice and patient outcomes. Cochrane Database Syst Rev, 6, 2012, CD000259.
17. 17. Ko, H.C., Turner, T.J., Finnigan, M.A., Systematic review of safety checklists for use by medical care teams in acute hospital settings—limited evidence of effectiveness. BMC Health Serv Res, 11(1), 2011, 211.
18. 18. Thankappan, K.R., Mini, G.K., Daivadanam, M., et al. Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India. BMC Public Health, 13(1), 2013 [1–1].
19. 19. Wood, L., Egger, M., Gluud, L.L., et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 336:7644 (2008), 601–605.
20. 20. Mehran, R., Rao, S.V., Bhatt, D.L., et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123:23 (2011), 2736–2747.
21. 21. Huffman, M.D., Rao, K.D., Pichon-Riviere, A., et al. A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS One, 6(6), 2011, e20821.
22. 22. Hemming, K., Haines, T.P., Chilton, P.J., et al. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ, 350, 2015, h391.
23. 23. Hemming, K., Girling, A., A menu-driven facility for power and detectable-difference calculations in stepped-wedge cluster-randomized trials. Stata J 14 (2014), 363–380.
24. 24. Boutron, I., Moher, D., Altman, D.G., et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148:4 (2008), 295–309.
25. 25. Granger, C.B., Goldberg, R.J., Dabbous, O., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163:19 (2003), 2345–2353.
26. 26. Kirkwood, A.A., Cox, T., Hackshaw, A., Application of methods for central statistical monitoring in clinical trials. Clin Trials 10:5 (2013), 783–806.
27. 27. Moore, G.F., Audrey, S., Barker, M., et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ, 350(mar19 6), 2015, h1258.
28. 28. Board on Global Health, Institute of Medicine, The National Academies of Sciences, Engineering, and Medicine, Improving quality of care in low- and middle-income countries: workshop summary. 2015, National Academies Press (US), Washington (DC).
29. 29. Jollis, J.G., Al-Khalidi, H.R., Roettig, M.L., et al. Regional systems of care demonstration project: clinical perspective. Circulation 134:5 (2016), 365–374.
30. 30. Ranasinghe, I., Rong, Y., Du, X., et al. System barriers to the evidence-based care of acute coronary syndrome patients in China: qualitative analysis. Circ Cardiovasc Qual Outcomes 7:2 (2014), 209–216.